Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors

被引:28
|
作者
Weitzenfeld, Polina [1 ]
Kossover, Olga [2 ]
Koerner, Cindy [3 ]
Meshel, Tsipi [1 ]
Wiemann, Stefan [3 ]
Seliktar, Dror [2 ]
Legler, Daniel F. [4 ]
Ben-Baruch, Adit [1 ]
机构
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel
[2] Technion Israel Inst Technol, Fac Biomed Engn, Haifa, Israel
[3] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany
[4] Univ Konstanz, Biotechnol Inst Thurgau, Constance, Germany
关键词
EPIDERMAL-GROWTH-FACTOR; INDUCED CELL-DEATH; UP-REGULATES CCR7; LYMPH-NODE; EXPRESSION PATTERNS; SIGNALING PATHWAYS; MOLECULAR SUBTYPES; PROTEIN EXPRESSION; PROGNOSTIC VALUE; DOWN-REGULATION;
D O I
10.1189/jlb.3MA0815-373R
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Chemokine axes have been shown to mediate site-specific metastasis in breast cancer, but their relevance to different subtypes has been hardly addressed. Here, with the focus on the CCR7-CCL21 axis, patient datasets demonstrated that luminal-A tumors express relatively low CCR7 levels compared with more aggressive disease subtypes. Furthermore, lymph node metastasis was not associated with high CCR7 levels in luminal-A patients. The metastatic pattern of luminal-A breast tumors may be influenced by the way luminal-A tumor cells interpret signals provided by factors of the primary tumor microenvironment. Thus, CCR7-expressing human luminal-A cells were stimulated simultaneously by factors representing 3 tumor microenvironment arms typical of luminal-A tumors, hormonal, inflammatory, and growth stimulating: estrogen + TNF-alpha + epidermal growth factor. Such tumor microenvironment stimulation down-regulated the migration of CCR7-expressing tumor cells toward CCL21 and inhibited the formation of directional protrusions toward CCL21 in a novel 3-dimensional hydrogel system. CCL21-induced migration of CCR7-expressing tumor cells depended on PI3K and MAPK activation; however, when CCR7-expressing cancer cells were prestimulated by tumor microenvironment factors, CCL21 could not effectively activate these signaling pathways. In vivo, pre-exposure of the tumor cells to tumor microenvironment factors has put restraints on CCL21-mediated lymph node-homing cues and shifted the metastatic pattern of CCR7-expressing cells to the aggressive phenotype of dissemination to bones. Several of the aspects were also studied in the CXCR4-CXCL12 system, demonstrating similar patient and in vitro findings. Thus, we provide novel evidence to subtype-specific regulation of the CCR7-CCL21 axis, with more general implications to chemokine-dependent patterns of metastatic spread, revealing differential regulation in the luminal-A subtype.
引用
收藏
页码:1009 / 1025
页数:17
相关论文
共 12 条
  • [1] Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells
    Weitzenfeld, Polina
    Meshel, Tsipi
    Ben-Baruch, Adit
    ONCOTARGET, 2016, 7 (49) : 81123 - 81143
  • [2] Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin
    Marks, Douglas K.
    Kucharczyk, John
    Kim, Pan
    Chyong, Donian, I
    Gartrell, Robyn D.
    Lu, Yan
    Hibshoosh, Hanina
    Guo, Hua
    Evans, Thomas R. Jeffry
    Lopez, Juanita
    Kristeleit, Rebecca
    Connolly, Eileen
    Saenger, Yvonne
    Kalinsky, Kevin
    CANCER INVESTIGATION, 2021, 39 (6-7) : 466 - 472
  • [3] Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients
    Franken, Andre
    Honisch, Ellen
    Reinhardt, Florian
    Meier-Stiegen, Franziska
    Yang, Liwen
    Jaschinski, Sandra
    Esposito, Irene
    Alberter, Barbara
    Polzer, Bernhard
    Huebner, Hanna
    Fasching, Peter A.
    Pancholi, Sunil
    Martin, Lesley-Ann
    Ruckhaeberle, Eugen
    Schochter, Fabienne
    Tzschaschel, Marie
    Hartkopf, Andreas D.
    Mueller, Volkmar
    Niederacher, Dieter
    Fehm, Tanja
    Neubauer, Hans
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (01): : 111 - 121
  • [4] C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
    Wani, Nissar Ahmad
    Nasser, Mohd W.
    Ahirwar, Dinesh K.
    Zhao, Helong
    Miao, Zhenhua
    Shilo, Konstantin
    Ganju, Ramesh K.
    BREAST CANCER RESEARCH, 2014, 16 (03)
  • [5] C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
    Nissar Ahmad Wani
    Mohd W Nasser
    Dinesh K Ahirwar
    Helong Zhao
    Zhenhua Miao
    Konstantin Shilo
    Ramesh K Ganju
    Breast Cancer Research, 16
  • [6] Tellurium-driven maple leaf-shaped manganese nanotherapeutics reshape tumor microenvironment via chemical transition in situ to achieve highly efficient radioimmunotherapy of triple negative breast cancer
    Huang, Wei
    Shi, Sujiang
    Lv, Haoran
    Ju, Zhenyu
    Liu, Qinghua
    Chen, Tianfeng
    BIOACTIVE MATERIALS, 2023, 27 : 560 - 573
  • [7] Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes
    Erlichman, Nofar
    Baram, Tamir
    Meshel, Tsipi
    Morein, Dina
    Da'adoosh, Benny
    Ben-Baruch, Adit
    CANCERS, 2022, 14 (04)
  • [8] The scaffolding protein, NHERF-1, is overexpressed in metastatic breast cancer and regulates tumor microenvironment-driven invasion via its PDZ2 domain
    Cardone, RA
    Bellizzi, A
    Bagorda, A
    Busco, G
    Casavola, V
    Reshkin, SJ
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 240A - 241A
  • [9] The tumor-immune microenvironment (TME) in HR+/HER2-metastatic breast cancer (mBC): Relationship to non-metastatic (met) tumors and prior treatment (tx) received.
    Waks, Adrienne Gropper
    Tolaney, Sara M.
    Schnitt, Stuart J.
    Dillon, Deborah
    Gjini, Evisa
    Abdelrahman, Sara
    Marino-Enriquez, Adrian
    Helvie, Karla
    Marini, Lori
    Cohen, Ofir
    Kim, Dewey
    Wander, Seth Andrew
    Stover, Daniel G.
    Rodig, Scott
    Krop, Ian E.
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer
    Zanker, Damien J.
    Spurling, Alex J.
    Brockwell, Natasha K.
    Owen, Katie L.
    Zakhour, Jasmine M.
    Robinson, Tina
    Duivenvoorden, Hendrika M.
    Hertzog, Paul J.
    Mullins, Stefanie R.
    Wilkinson, Robert W.
    Parker, Belinda S.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (09)